{"id":329303,"date":"2026-10-28T10:13:39","date_gmt":"2026-10-28T04:43:39","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=329303"},"modified":"2026-10-28T10:13:39","modified_gmt":"2026-10-28T04:43:39","slug":"midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/","title":{"rendered":"4 Midcap Revenue CAGR 10-15 Per Cent Stocks to Watch for Future Multibagger Potential: Fortis Healthcare, LTTS, Hindustan Copper and Astral"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Fortis Healthcare Rs 736.50. LTTS Rs 4,174.20. Hindustan Copper Rs 407.35. Astral Rs 1,376. Market caps from Rs 37,358 crore to Rs 56,063 crore. Data as of 27 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Fortis Healthcare, LTTS, Hindustan Copper and Astral are the 4 picks in this revenue CAGR 10-15 per cent stocks watchlist, with market caps between Rs 37,358 crore and Rs 56,063 crore. Fortis Healthcare stands out for the biggest five-year price gain at 241.47%, while LTTS offers the lowest PE of the group at 33.48. PE ratios run from 33.48 to 64.89, so compare each one with its industry PE before investing. All figures are as of 27 October 2026.<\/p>\n<\/p><\/div>\n<p>Revenue CAGR 10-15 per cent stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Fortis Healthcare, LTTS, Hindustan Copper and Astral meet that test, with market caps from Rs 37,358 crore to Rs 56,063 crore and Fortis Healthcare offering the biggest five-year price gain at 241.47%. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a four-year revenue CAGR between 10 and 15 per cent from FY22 to FY26, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.<\/p>\n<p>This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a four-year revenue CAGR between 10 and 15 per cent from FY22 to FY26, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening revenue CAGR 10-15 per cent stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 27 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=revenue-cagr-per-cent-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#What_Are_Revenue_CAGR_10-15_Per_Cent_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Revenue CAGR 10-15 Per Cent Stocks and Why Do They Attract Multibagger Interest?\">What Are Revenue CAGR 10-15 Per Cent Stocks and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#Revenue_CAGR_10-15_Per_Cent_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\" title=\"Revenue CAGR 10-15 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE\">Revenue CAGR 10-15 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#Fortis_Healthcare_Five-Year_Gain_of_24147\" title=\"Fortis Healthcare: Five-Year Gain of 241.47%\">Fortis Healthcare: Five-Year Gain of 241.47%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#LTTS_Debt-to-Equity_of_009\" title=\"LTTS: Debt-to-Equity of 0.09\">LTTS: Debt-to-Equity of 0.09<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#Hindustan_Copper_2525_Profit_CAGR_Since_FY22\" title=\"Hindustan Copper: 25.25% Profit CAGR Since FY22\">Hindustan Copper: 25.25% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#Astral_Debt-to-Equity_of_006\" title=\"Astral: Debt-to-Equity of 0.06\">Astral: Debt-to-Equity of 0.06<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#Revenue_CAGR_10-15_Per_Cent_Stocks_Financial_Comparison_on_Growth_and_Margins\" title=\"Revenue CAGR 10-15 Per Cent Stocks: Financial Comparison on Growth and Margins\">Revenue CAGR 10-15 Per Cent Stocks: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#Institutional_Holding_in_Fortis_Healthcare_LTTS_Hindustan_Copper_and_Astral\" title=\"Institutional Holding in Fortis Healthcare, LTTS, Hindustan Copper and Astral\">Institutional Holding in Fortis Healthcare, LTTS, Hindustan Copper and Astral<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Revenue_CAGR_10-15_Per_Cent_Stocks\" title=\"Risks to Weigh in Revenue CAGR 10-15 Per Cent Stocks\">Risks to Weigh in Revenue CAGR 10-15 Per Cent Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#How_to_Choose_Between_Revenue_CAGR_10-15_Per_Cent_Stocks\" title=\"How to Choose Between Revenue CAGR 10-15 Per Cent Stocks\">How to Choose Between Revenue CAGR 10-15 Per Cent Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Revenue_CAGR_10-15_Per_Cent_Stocks_to_Watch\" title=\"Frequently Asked Questions on Revenue CAGR 10-15 Per Cent Stocks to Watch\">Frequently Asked Questions on Revenue CAGR 10-15 Per Cent Stocks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#Which_are_the_best_revenue_CAGR_10-15_per_cent_stocks_to_watch_for_multibagger_potential\" title=\"Which are the best revenue CAGR 10-15 per cent stocks to watch for multibagger potential?\">Which are the best revenue CAGR 10-15 per cent stocks to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#Is_Hindustan_Copper_a_good_stock_for_long-term_investors\" title=\"Is Hindustan Copper a good stock for long-term investors?\">Is Hindustan Copper a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#Can_Fortis_Healthcare_become_a_multibagger_from_here\" title=\"Can Fortis Healthcare become a multibagger from here?\">Can Fortis Healthcare become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Fortis_Healthcare_LTTS_Hindustan_Copper_and_Astral\" title=\"What is the market cap of Fortis Healthcare, LTTS, Hindustan Copper and Astral?\">What is the market cap of Fortis Healthcare, LTTS, Hindustan Copper and Astral?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_revenue_CAGR_10-15_per_cent_stocks\" title=\"What are the risks of investing in revenue CAGR 10-15 per cent stocks?\">What are the risks of investing in revenue CAGR 10-15 per cent stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#Why_is_Hindustan_Copper_trading_at_a_PE_of_3562\" title=\"Why is Hindustan Copper trading at a PE of 35.62?\">Why is Hindustan Copper trading at a PE of 35.62?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Fortis_Healthcare_LTTS_Hindustan_Copper_and_Astral\" title=\"How much do institutions hold in Fortis Healthcare, LTTS, Hindustan Copper and Astral?\">How much do institutions hold in Fortis Healthcare, LTTS, Hindustan Copper and Astral?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Revenue_CAGR_10-15_Per_Cent_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Revenue CAGR 10-15 Per Cent Stocks and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Revenue CAGR 10-15 per cent stocks are shares of mid sized companies whose sales compounded at 10 to 15 per cent a year between FY22 and FY26, a steady expansion that comes from real demand rather than one lucky year. The four here cover hospitals, engineering research services, copper and pipes.<\/p>\n<p>Sales that grow at a double digit pace year after year show that customers keep coming back, which is the base on which profit growth is built. For revenue CAGR 10-15 per cent stocks, both FY26 and the latest quarter showed growth. For revenue CAGR 10-15 per cent stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of revenue CAGR 10-15 per cent stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for revenue CAGR 10-15 per cent stocks before you decide.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Revenue_CAGR_10-15_Per_Cent_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\"><\/span><strong>Revenue CAGR 10-15 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 27 October 2026. LTTS has the lowest PE of the group at 33.48, while Hindustan Copper posts the highest return on equity at 27.48%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/fortis\/fortis-healthcare-ltd-share-price-today\">Fortis Healthcare<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">736.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">56,063<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">52.37<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">60.75<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.35<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">565.00 to 757.40<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ltts\/landt-technology-services-ltd-share-price-today\">L&amp;T Technology Services<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,174.20<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">44,254<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">33.48<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.66<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19.76%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.09<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,010.00 to 4,726.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hindcopper\/hindustan-copper-ltd-share-price-today\">Hindustan Copper<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">407.35<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">40,468<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">35.62<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.27<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">27.48%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.03<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">308.50 to 760.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/astral\/astral-ltd-share-price-today\">Astral<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,376<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">37,358<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">64.89<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.61<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.18%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.06<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,311.60 to 1,768.70<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Fortis_Healthcare_Five-Year_Gain_of_24147\"><\/span><strong>Fortis Healthcare: Five-Year Gain of 241.47%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Fortis Healthcare operates a chain of hospitals and diagnostic centres across India. It reported FY26 revenue of Rs 9,178.50 crore, up 16.93% year on year, and net profit of Rs 1,064.19 crore, up 31.48%. Net profit has compounded at 7.73% a year since FY22, while revenue has grown 12.43% a year. Operating margin was 22.41% in FY26. The debt-to-equity ratio is 0.35.<\/p>\n<p>In the June 2026 quarter, revenue rose 17.29% to Rs 2,559.50 crore and net profit grew 2.26% to Rs 272.80 crore. The share price has gained 241.47% over five years. Domestic institutions raised their holding from 29.79% in June 2025 to 32.23% in June 2026. The stock trades at a PE of 52.37 against an industry PE of 60.75, below the sector average.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"LTTS_Debt-to-Equity_of_009\"><\/span><strong>LTTS: Debt-to-Equity of 0.09<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>L&amp;T Technology Services provides engineering and R&amp;D services for global customers in mobility, sustainability and tech industries. It reported FY26 revenue of Rs 11,217.10 crore, up 13.86% year on year, and net profit of Rs 1,230 crore, up 3.37%. Net profit has compounded at 6.38% a year since FY22, while revenue has grown 13.66% a year. Operating margin was 19.42% in FY26. The debt-to-equity ratio is 0.09, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 33.48 against an industry PE of 17.66, with a return on equity of 19.76%. In the June 2026 quarter, revenue rose 9.79% to Rs 2,969.20 crore and net profit grew 12.97% to Rs 357.10 crore. Promoters hold 73.53%, which keeps ownership stable.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Hindustan_Copper_2525_Profit_CAGR_Since_FY22\"><\/span><strong>Hindustan Copper: 25.25% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Hindustan Copper is a government-owned company that mines copper ore and produces refined copper in India. It reported FY26 revenue of Rs 3,149.67 crore, up 46.62% year on year, and net profit of Rs 920.66 crore, up 96.97%. Net profit has compounded at 25.25% a year since FY22, while revenue has grown 13.89% a year. Operating margin was 46.74% in FY26. The debt-to-equity ratio is 0.03, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 81.07% to Rs 953.60 crore and net profit grew 162.59% to Rs 352.61 crore. The share price has gained 205.23% over five years and 33.08% over the past year. Foreign investors raised their holding from 3.71% in June 2025 to 5.96% in June 2026. The stock trades at a PE of 35.62 against an industry PE of 12.27, with a return on equity of 27.48%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Astral_Debt-to-Equity_of_006\"><\/span><strong>Astral: Debt-to-Equity of 0.06<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Astral makes CPVC and PVC pipes, fittings, adhesives and water tanks for plumbing and drainage in homes and buildings. It reported FY26 revenue of Rs 6,615.90 crore, up 12.64% year on year, and net profit of Rs 534.70 crore, up 3.04%. Revenue has compounded at 10.55% a year since FY22. Operating margin was 16.54% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 64.89 against an industry PE of 36.61, with a return on equity of 13.18%. In the June 2026 quarter, revenue rose 16.09% to Rs 1,590.80 crore and net profit grew 51.77% to Rs 120.20 crore. Domestic institutions raised their holding from 14.90% in June 2025 to 21.31% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Revenue_CAGR_10-15_Per_Cent_Stocks_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Revenue CAGR 10-15 Per Cent Stocks: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these revenue CAGR 10-15 per cent stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Net Profit CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Fortis Healthcare<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9,178.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,064.19<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.93%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.43%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.73%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">LTTS<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11,217.10<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,230<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.86%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.66%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6.38%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19.80%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Hindustan Copper<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,149.67<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">920.66<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">46.62%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.89%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">25.25%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">56.02%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Astral<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6,615.90<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">534.70<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.64%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.55%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2.19%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.46%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these revenue CAGR 10-15 per cent stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Fortis_Healthcare_LTTS_Hindustan_Copper_and_Astral\"><\/span><strong>Institutional Holding in Fortis Healthcare, LTTS, Hindustan Copper and Astral<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these revenue CAGR 10-15 per cent stocks alongside the promoter. The table uses the latest reported quarter for each. Fortis Healthcare has the deepest institutional backing, with FII and DII together holding 57.43% as of June 2026. Domestic institutions increased their holding over the past year in Fortis Healthcare (from 29.79% to 32.23%) and Astral (from 14.90% to 21.31%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Fortis Healthcare<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">31.17%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">25.20%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.23%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.40%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">LTTS<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">73.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4.12%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.05%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8.30%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Hindustan Copper<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">66.14%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.96%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4.84%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.06%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Astral<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">54.22%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.89%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.31%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.58%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Revenue_CAGR_10-15_Per_Cent_Stocks\"><\/span><strong>Risks to Weigh in Revenue CAGR 10-15 Per Cent Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with revenue CAGR 10-15 per cent stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> Hindustan Copper trades at a PE of 35.62 against an industry PE of 12.27, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Revenue_CAGR_10-15_Per_Cent_Stocks\"><\/span><strong>How to Choose Between Revenue CAGR 10-15 Per Cent Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from revenue CAGR 10-15 per cent stocks comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (12.27 to 60.75) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Fortis Healthcare, LTTS, Hindustan Copper and Astral live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among revenue CAGR 10-15 per cent stocks, Fortis Healthcare stands out for the biggest five-year price gain at 241.47%, LTTS for the lowest PE of the group at 33.48, Hindustan Copper for the highest return on equity at 27.48% and Astral for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing revenue CAGR 10-15 per cent stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Revenue_CAGR_10-15_Per_Cent_Stocks_to_Watch\"><\/span><strong>Frequently Asked Questions on Revenue CAGR 10-15 Per Cent Stocks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_revenue_CAGR_10-15_per_cent_stocks_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best revenue CAGR 10-15 per cent stocks to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Fortis Healthcare, LTTS, Hindustan Copper and Astral are the 4 names this list highlights, with market caps of Rs 56,063 crore, Rs 44,254 crore, Rs 40,468 crore and Rs 37,358 crore respectively. Fortis Healthcare is notable for the biggest five-year price gain at 241.47%. LTTS stands out for the lowest PE of the group at 33.48. Hindustan Copper offers the highest return on equity at 27.48%. Astral brings a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. These are watchlist names for revenue CAGR 10-15 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Hindustan_Copper_a_good_stock_for_long-term_investors\"><\/span><strong>Is Hindustan Copper a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Hindustan Copper has a return on equity of 27.48%, a PE of 35.62 against an industry PE of 12.27 and a market cap of Rs 40,468 crore. Net profit has compounded at 25.25% a year since FY22, and FY26 revenue rose 46.62% while June 2026 quarter net profit grew 162.59%. Long-term returns in revenue CAGR 10-15 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Fortis_Healthcare_become_a_multibagger_from_here\"><\/span><strong>Can Fortis Healthcare become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Fortis Healthcare has already gained 241.47% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in revenue CAGR 10-15 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 7.73% a year since FY22, and FY26 revenue rose 16.93%. At a PE of 52.37 against an industry PE of 60.75, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Fortis_Healthcare_LTTS_Hindustan_Copper_and_Astral\"><\/span><strong>What is the market cap of Fortis Healthcare, LTTS, Hindustan Copper and Astral?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 27 October 2026, Fortis Healthcare has a market cap of Rs 56,063 crore, LTTS has a market cap of Rs 44,254 crore, Hindustan Copper has a market cap of Rs 40,468 crore and Astral has a market cap of Rs 37,358 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on revenue CAGR 10-15 per cent stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_revenue_CAGR_10-15_per_cent_stocks\"><\/span><strong>What are the risks of investing in revenue CAGR 10-15 per cent stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Hindustan Copper trades at a PE of 35.62 against an industry PE of 12.27, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Hindustan_Copper_trading_at_a_PE_of_3562\"><\/span><strong>Why is Hindustan Copper trading at a PE of 35.62?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Hindustan Copper&#8217;s PE of 35.62 compares with an industry PE of 12.27. The market is paying a premium for a return on equity of 27.48%, profit growth of 25.25% a year since FY22 and latest-quarter profit growth of 162.59%, which also means the stock is more sensitive if growth slows. Investors in revenue CAGR 10-15 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Fortis_Healthcare_LTTS_Hindustan_Copper_and_Astral\"><\/span><strong>How much do institutions hold in Fortis Healthcare, LTTS, Hindustan Copper and Astral?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 57.43% of Fortis Healthcare (25.20% and 32.23%), 18.17% of LTTS (4.12% and 14.05%), 10.80% of Hindustan Copper (5.96% and 4.84%) and 35.20% of Astral (13.89% and 21.31%). Rising institutional holding is a useful signal in revenue CAGR 10-15 per cent stocks, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best revenue CAGR 10-15 per cent stocks to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Fortis Healthcare, LTTS, Hindustan Copper and Astral are the 4 names this list highlights, with market caps of Rs 56,063 crore, Rs 44,254 crore, Rs 40,468 crore and Rs 37,358 crore respectively. Fortis Healthcare is notable for the biggest five-year price gain at 241.47%. LTTS stands out for the lowest PE of the group at 33.48. Hindustan Copper offers the highest return on equity at 27.48%. Astral brings a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. These are watchlist names for revenue CAGR 10-15 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is Hindustan Copper a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Hindustan Copper has a return on equity of 27.48%, a PE of 35.62 against an industry PE of 12.27 and a market cap of Rs 40,468 crore. Net profit has compounded at 25.25% a year since FY22, and FY26 revenue rose 46.62% while June 2026 quarter net profit grew 162.59%. Long-term returns in revenue CAGR 10-15 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Fortis Healthcare become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Fortis Healthcare has already gained 241.47% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in revenue CAGR 10-15 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 7.73% a year since FY22, and FY26 revenue rose 16.93%. At a PE of 52.37 against an industry PE of 60.75, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Fortis Healthcare, LTTS, Hindustan Copper and Astral?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 27 October 2026, Fortis Healthcare has a market cap of Rs 56,063 crore, LTTS has a market cap of Rs 44,254 crore, Hindustan Copper has a market cap of Rs 40,468 crore and Astral has a market cap of Rs 37,358 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on revenue CAGR 10-15 per cent stocks.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in revenue CAGR 10-15 per cent stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Hindustan Copper trades at a PE of 35.62 against an industry PE of 12.27, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Hindustan Copper trading at a PE of 35.62?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Hindustan Copper's PE of 35.62 compares with an industry PE of 12.27. The market is paying a premium for a return on equity of 27.48%, profit growth of 25.25% a year since FY22 and latest-quarter profit growth of 162.59%, which also means the stock is more sensitive if growth slows. Investors in revenue CAGR 10-15 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Fortis Healthcare, LTTS, Hindustan Copper and Astral?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 57.43% of Fortis Healthcare (25.20% and 32.23%), 18.17% of LTTS (4.12% and 14.05%), 10.80% of Hindustan Copper (5.96% and 4.84%) and 35.20% of Astral (13.89% and 21.31%). Rising institutional holding is a useful signal in revenue CAGR 10-15 per cent stocks, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 midcap revenue CAGR 10-15 per cent stocks compared on market cap, PE, ROE, growth and institutional holding: Fortis Healthcare, LTTS, Hindustan Copper and Astral.<\/p>\n","protected":false},"author":33,"featured_media":329302,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[16931,16932],"class_list":["post-329303","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-revenue-cagr-10-15-per-cent-stocks","tag-revenue-cagr-between-10-and-15-per-cent-sector"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["329302"],"rank_math_title":["Revenue CAGR 10-15 Per Cent Stocks 2026: Fortis Healthcare, LTTS"],"rank_math_description":["Revenue CAGR 10-15 per cent stocks to watch for multibagger potential: Fortis Healthcare, LTTS, Hindustan Copper and Astral. Compare market cap, PE, ROE and growth."],"rank_math_focus_keyword":["revenue CAGR 10-15 per cent stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/4-midcap-revenue-cagr-10-15-per-cent-stocks-to-watch-for-future-multibagger.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/329303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=329303"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/329303\/revisions"}],"predecessor-version":[{"id":329304,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/329303\/revisions\/329304"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/329302"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=329303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=329303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=329303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}